You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoadjuvant endocrine therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer. Real Clinical Practice in Russia

Recruiting
  • Breast Cancer
  • Neoadjuvant Endocrine Therapy
  • Tamoxifen 20mg
  • +4 more
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 5, 2023

Breast Cancer Trial in Tianjin (Dalcelli?Exemestane?Gosserine, Docetaxel for injection?Epirubicin HCl for

Recruiting
  • Breast Cancer
  • Tianjin, Tianjin, China
    Jie Ge
Aug 20, 2023

Female Breast Cancer Trial in Sohag (Hormonal Antineoplastics, Chemotherapy drug)

Not yet recruiting
  • Female Breast Cancer
  • Hormonal Antineoplastics
  • Chemotherapy drug
  • Sohag, Egypt
    amal Ali
Feb 23, 2023

Locally Advanced Breast Cancer, Hormone Receptor Positive,HER2-negative Breast Cancer Trial in Jinan (letrozole)

Recruiting
  • Locally Advanced Breast Cancer
  • Hormone Receptor Positive，HER2-negative Breast Cancer
  • Jinan, Shandong, China
    Breast Cancer Center, Shandong Cancer Hospital and Institute
Apr 11, 2023

Breast Cancer Trial in Shijiazhuang (Dalpiciclib, Aromatase inhibitor, Docetaxel injection)

Recruiting
  • Breast Cancer
  • Shijiazhuang, Hebei, China
    The Fourth Hospital of Hebei Medical University
Oct 25, 2023

HER2-positive Breast Cancer Trial (Inavolisib, PHESGO, Endocrine therapy)

Not yet recruiting
  • HER2-positive Breast Cancer
  • (no location specified)
Mar 23, 2022

Breast Cancer Female Trial in Charlottesville, Richmond (tamoxifen, letrozole, anastrozole, or exemestane, Patient reported

Recruiting
  • Breast Cancer Female
  • tamoxifen, letrozole, anastrozole, or exemestane
  • Patient reported outcomes
  • Charlottesville, Virginia
  • +1 more
Mar 16, 2022

Breast Cancer, HER2-negative Breast Cancer, Node-negative Breast Cancer Trial in Lexington (Anastrozole 1mg, Letrozole 2.5mg,

Recruiting
  • Breast Cancer
  • +3 more
  • Anastrozole 1mg
  • +3 more
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Jan 3, 2022

Breast Cancer Trial in United States (Avelumab, Endocrine therapy, Palbociclib)

Recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +3 more
Apr 15, 2022

Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer Trial in Nanjing (ADT, Abiraterone Acetate,

Recruiting
  • Neoadjuvant Therapy
  • +3 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Aug 12, 2022

Breast Cancer, Breast Carcinoma, Malignant Tumor of Breast Trial in Saint Louis, Columbus (Mammaglobin-A DNA Vaccine, Optional

Recruiting
  • Breast Cancer
  • +2 more
  • Mammaglobin-A DNA Vaccine
  • Optional biopsy
  • Saint Louis, Missouri
  • +1 more
Jan 26, 2022

Breast Cancer, Invasive Breast Cancer Trial in Milwaukee (Anastrozole, Letrozole, Exemestane)

Active, not recruiting
  • Breast Cancer
  • Invasive Breast Cancer
  • Milwaukee, Wisconsin
    Froedtert Hospital
Sep 16, 2021

High-Risk and Oligometastatic Prostate Cancer Trial (Apalutamide)

Not yet recruiting
  • High-Risk and Oligometastatic Prostate Cancer
  • (no location specified)
Aug 2, 2021

Breast Cancer Trial (Patritumab deruxtecan, Chemotherapy, Letrozole)

Recruiting
  • Breast Cancer
  • Patritumab deruxtecan
  • +2 more
  • Barcelona, Spain
    Hospital Clinic de Barcelona
Nov 28, 2022

Luminal B/HER2-negative Breast Cancer Trial in Hangzhou (Dalpiciclib combined with aromatase inhibitors,

Recruiting
  • Luminal B/HER2-negative Breast Cancer
  • Dalpiciclib combined with aromatase inhibitors
  • anthracycline-cyclophosphamide followed by taxane
  • Hangzhou, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Nov 30, 2022

Breast Cancer Female Trial in Belgium (Palbociclib)

Completed
  • Breast Cancer Female
  • Anderlecht, Belgium
  • +4 more
Jun 23, 2022

Clinical Outcomes in HR+ and HER2-low/Negative Breast Cancer

Active, not recruiting
  • Hormone-receptor-positive Breast Cancer
  • +2 more
  • No drug
  • Cambridge, Massachusetts
    ConcertAI database
Sep 8, 2023

Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, Anatomic Stage III Breast Cancer Trial in United States

Not yet recruiting
  • Anatomic Stage I Breast Cancer
  • +3 more
  • Endocrine Therapy
  • +7 more
  • Atlanta, Georgia
  • +4 more
Jun 15, 2023

Breast Cancer Trial in Omaha (Palbociclib 125mg)

Recruiting
  • Breast Cancer
  • Palbociclib 125mg
  • Omaha, Nebraska
    Nebraska Medicine
Mar 3, 2022

Invasive Lobular Breast Carcinoma, ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Belgium, France (Entrectinib,

Recruiting
  • Invasive Lobular Breast Carcinoma
  • +2 more
  • Brussels, Belgium
  • +9 more
May 4, 2022

Breast Cancer Trial in Norway (drug, procedure, radiation)

Active, not recruiting
  • Breast Cancer
  • Neoadjuvant tamoxifen + goserelin (premenopausal women)
  • +15 more
  • Lørenskog, Akershus, Norway
  • +6 more
Aug 24, 2021

Breast Tumors Trial in Mönchengladbach (drug, diagnostic test, procedure)

Active, not recruiting
  • Breast Neoplasms
  • Perjeta Injectable Product
  • +13 more
  • Mönchengladbach, Germany
    Evangelisches Krankenhaus Bethesda Mönchengladbach
Oct 4, 2022

Development of Patient Derived Xenografts (PDX) in Breast Cancer

Recruiting
  • Breast Cancer
  • Residual
  • chemotherapy or endocrine therapy for breast cancer
  • Rochester, Minnesota
    Mayo Clinic
Feb 3, 2022

Breast Cancer Trial in United States (Lapatinib, Letrozole, Trastuzumab)

Active, not recruiting
Has Results
  • Breast Cancer
  • Birmingham, Alabama
  • +7 more
May 15, 2022

Pancreas Cancer Trial in Halle (Saale) (Visceral Debranching)

Recruiting
  • Pancreas Cancer
  • Visceral Debranching
  • Halle (Saale), Germany
    University Hospital, Dpt. of Visceral, Vascular and Endocrine Su
Sep 27, 2021